{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:05:04Z","timestamp":1787990704475,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.hbpd.2020.06.017","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:15:00Z","timestamp":1593530100000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Challenge to ABO blood type barrier in living donor liver transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Hiroto","family":"Egawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.06.017_bib0001","first-page":"231","article-title":"Human ABO-incompatible living donor renal homografts","volume":"28","author":"Alexandre","year":"1985","journal-title":"Neth J Med"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00007890-199504270-00009","article-title":"The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients","volume":"59","author":"Farges","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.TP.0000110295.88926.5C","article-title":"Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation","volume":"77","author":"Egawa","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0004","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","article-title":"Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation","volume":"73","author":"Tanabe","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.transproceed.2005.03.148","article-title":"New protocol of immunosuppression for liver transplantation across ABO barrier: the use of rituximab, hepatic arterial infusion, and preservation of spleen","volume":"37","author":"Yoshizawa","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study","volume":"14","author":"Egawa","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0008","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2014.04.039","article-title":"Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era","volume":"61","author":"Song","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ajt.13444","article-title":"ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab","volume":"16","author":"Song","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/lt.20002","article-title":"Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation","volume":"10","author":"Haga","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0011","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","article-title":"Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation","volume":"12","author":"Haga","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0012","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","article-title":"ABO-incompatible kidney transplantation","volume":"27","author":"Takahashi","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0014","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.transproceed.2005.03.129","article-title":"Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation","volume":"37","author":"Zhou","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2008.00821.x","article-title":"Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients","volume":"22","author":"Toki","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jhbp.419","article-title":"Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation","volume":"24","author":"Egawa","year":"2017","journal-title":"J Hepatob Pancreat Sci"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0017","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3181adcae6","article-title":"Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation","volume":"88","author":"Ikegami","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/TP.0b013e318239e8e4","article-title":"Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab","volume":"93","author":"Raut","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0019","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jhep.2018.02.002","article-title":"Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma","volume":"68","author":"Yoon","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0000000000002154","article-title":"ABO-incompatible living donor liver transplantation with rituximab and total plasma exchange does not increase hepatocellular carcinoma recurrence","volume":"102","author":"Kim","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0021","first-page":"892","article-title":"Impact of desensitization for ABO-blood barrier on living donor liver transplantation for hepatocellular carcinoma","volume":"111","author":"Egawa","year":"2014","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0022","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00007890-199510150-00024","article-title":"A reassessment of ABO incompatibility in pediatric liver transplantation","volume":"60","author":"Cacciarelli","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0023","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/TP.0000000000002197","article-title":"Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation","volume":"102","author":"Honda","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0024","doi-asserted-by":"crossref","first-page":"e13308","DOI":"10.1111\/petr.13308","article-title":"ABO-incompatible liver transplantation for children under 2 years of age: a case report and a single-center review","volume":"23","author":"Narumoto","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0025","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1097\/TXD.0000000000000858","article-title":"Low titers of antidonor ABO antibodies after ABO-incompatible living donor liver transplantation: a long-term follow-up study","volume":"5","author":"Ueda","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0026","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1600-6143.2007.01901.x","article-title":"Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation","volume":"7","author":"Ohdan","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0027","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00007890-199801270-00020","article-title":"Ten-year experience in transplantation of A2 kidneys into B and O recipients","volume":"65","author":"Nelson","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0028","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.transproceed.2006.07.025","article-title":"Successful ABO-incompatible liver transplantation using A2 donors","volume":"38","author":"Skogsberg","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1034\/j.1600-6143.2002.020115.x","article-title":"Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?","volume":"2","author":"Nelson","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0031","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1097\/TXD.0000000000000932","article-title":"Bortezomib against refractory antibody-mediated rejection after ABO-incompatible living-donor liver transplantation: dramatic effect in acute-phase?","volume":"5","author":"Tajima","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0032","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/ajt.13871","article-title":"Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0033","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1600-6143.2008.02222.x","article-title":"C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients","volume":"8","author":"Rother","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0034","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/TXD.0000000000000683","article-title":"Effect of Fc-\u03b3 receptor polymorphism on rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation","volume":"3","author":"Sakai","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.hbpd.2020.06.017_bib0035","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10620-008-0618-y","article-title":"Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:41:42Z","timestamp":1761493302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1499387220301326"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.06.017","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenge to ABO blood type barrier in living donor liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}